Background Dyslipidemia is a well-known risk factor for cardiovascular disease (CVD), accounting for more than half of all instances of coronary artery disease globally (CAD). Purpose The purpose of this study was to determine lipid-related cardiovascular risks in HIV-positive and HIV-negative individuals by evaluating lipid profiles, ratios, and other related parameters. Methods A hospital-based study was carried out from January 2019 to February 2021 in both HIV + and HIV- ambulatory patients. Results High TG (p = .003), high TC (p = .025), and low HDL (p < .001) were all associated with a two-fold increased risk of CVD in people aged 45 and up. Due to higher TG (p < .001) and lower HDL (p < .001), males were found to have a higher risk o...
Background: Although half of HIV-infected patients develop lipodystrophy and metabolic complications...
Objective: To determine factors associated with increased risk of developing cardiovascular disease ...
BACKGROUND: Because of the known relationship between exposure to combination antiretroviral therapy...
WOS: 000398125400007PubMed ID: 28424436Objective: Dyslipidemia is a major complication of antiretrov...
Background Mortality due to cardiovascular disease among HIV patients is a concern in both developed...
PubMed ID: 28424436Objective: Dyslipidemia is a major complication of antiretroviral treatment. Aim ...
Objective: To determine the prevalence of risk factors for cardiovascular disease (CVD) among HIV-in...
OBJECTIVE: To determine the prevalence of risk factors for cardiovascular disease (CVD) among HIV-in...
Objective: To determine the prevalence of risk factors for cardiovascular disease (CVD) among HIV-in...
Objective: To determine the prevalence of risk factors for cardiovascular disease (CVD) among HIV-in...
BACKGROUND: The increased risk of coronary artery disease in human immunodeficiency virus (HIV) posi...
Background: Previous reports showed lack of consensus on the possible etiology of coronary artery di...
The increased risk of coronary artery disease in human immunodeficiency virus (HIV) positive patient...
The increased risk of coronary artery disease in human immunodeficiency virus (HIV) positive patient...
Abstract: The frequency of coronary heart disease (CHD) is increasing among HIV seropositive persons...
Background: Although half of HIV-infected patients develop lipodystrophy and metabolic complications...
Objective: To determine factors associated with increased risk of developing cardiovascular disease ...
BACKGROUND: Because of the known relationship between exposure to combination antiretroviral therapy...
WOS: 000398125400007PubMed ID: 28424436Objective: Dyslipidemia is a major complication of antiretrov...
Background Mortality due to cardiovascular disease among HIV patients is a concern in both developed...
PubMed ID: 28424436Objective: Dyslipidemia is a major complication of antiretroviral treatment. Aim ...
Objective: To determine the prevalence of risk factors for cardiovascular disease (CVD) among HIV-in...
OBJECTIVE: To determine the prevalence of risk factors for cardiovascular disease (CVD) among HIV-in...
Objective: To determine the prevalence of risk factors for cardiovascular disease (CVD) among HIV-in...
Objective: To determine the prevalence of risk factors for cardiovascular disease (CVD) among HIV-in...
BACKGROUND: The increased risk of coronary artery disease in human immunodeficiency virus (HIV) posi...
Background: Previous reports showed lack of consensus on the possible etiology of coronary artery di...
The increased risk of coronary artery disease in human immunodeficiency virus (HIV) positive patient...
The increased risk of coronary artery disease in human immunodeficiency virus (HIV) positive patient...
Abstract: The frequency of coronary heart disease (CHD) is increasing among HIV seropositive persons...
Background: Although half of HIV-infected patients develop lipodystrophy and metabolic complications...
Objective: To determine factors associated with increased risk of developing cardiovascular disease ...
BACKGROUND: Because of the known relationship between exposure to combination antiretroviral therapy...